Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article

Pati Aji Achdiat,1,2 Oki Suwarsa,1,2 Yudi Mulyana Hidayat,2,3 Mohamad Nasir Shafiee,4 Reiva Farah Dwiyana,1,2 Reti Hindritiani,1 Endang Sutedja,1 Satiti Retno Pudjiati,5 Dany Hilmanto,2,6 Meita Dhamayanti,2,6 Ida Parwati,2,7 Retno Hesty Maharani,1 Eva Krishna Sutedja,1 Erda Avriyanti,1 Yunitasari1 1...

Descripció completa

Dades bibliogràfiques

Autors principals:	Achdiat PA, Suwarsa O, Hidayat YM, Shafiee MN, Dwiyana RF, Hindritiani R, Sutedja E, Pudjiati SR, Hilmanto D, Dhamayanti M, Parwati I, Maharani RH, Sutedja EK, Avriyanti E, Yunitasari
Format:	Artigo
Idioma:	Inglês
Publicat:	Dove Medical Press 2024-03-01
Col·lecció:	ImmunoTargets and Therapy
Matèries:	anogenital warts condyloma acuminata cutaneous warts human papillomavirus immunotherapy tuberculin purified protein derivative
Accés en línia:	https://www.dovepress.com/efficacy-and-safety-profile-of-tuberculin-protein-purified-derivative--peer-reviewed-fulltext-article-ITT
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!